Results 191 to 200 of about 270,609 (355)

Usage history of three mass comparators in the past 20 years [PDF]

, 2017
Masaaki Ueki, Jianxin Sun, Kazunaga Ueda
openalex   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Hardware acceleration of number theoretic transform for zk‐SNARK

Engineering Reports, EarlyView., 2023
An FPGA‐based hardware accelerator with a multi‐level pipeline is designed to support the large‐bitwidth and large‐scale NTT tasks in zk‐SNARK. It can be flexibly scaled to different scales of FPGAs and has been equipped in the heterogeneous acceleration system with the help of HLS and OpenCL.
Haixu Zhao, Dong Ding, Feng Wang, Pengcheng Hua, Ning Wang, Qin Wu, Zhilei Chai   +6 more
wiley   +1 more source

Meta-Reinforcement Learning with Universal Policy Adaptation: Provable Near-Optimality under All-task Optimum Comparator [PDF]

Siyuan Xu, Minghui Zhu
openalex   +1 more source

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S. [PDF]

, 2013
David W. Kaufman, Shoshana Reshef, Howard L. Golub, Mark Peucker, Michael J. Corwin, Douglas S. Goodin, Volker Knappertz, Dirk Pleimes, Gary Cutter   +8 more
openalex   +1 more source

User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial [PDF]

, 2020
Michael A. Gibney, David Fitzpatrick, David C. Klonoff, Shahista Whooley, Betty Lu, Wen Yue, Stanislav Glezer   +6 more
openalex   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

A 1.2-V 7.76-ENOB 1-MS/s single-ended SAR ADC in 65-nm CMOS for biomedical applications. [PDF]

Sci Rep
Arafa KI, Ellaithy DM, Shawkey H, Abouelatta M, Zekry A.   +4 more
europepmc   +1 more source

Ultra‐low‐voltage low‐power dynamic comparator with forward body bias scheme for SAR ADC [PDF]

, 2018
Young‐Ha Hwang, Deog‐Kyoon Jeong
openalex   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source